STAAR Surgical Company - Common Stock (NQ:STAA)

22.47 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about STAAR Surgical Company - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 21, 2023

February 07, 2023

From STAAR Surgical Company

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For February 6, 2023 ↗

February 06, 2023

Via Benzinga

Analyst Reiterates This Ophthalmology Device Stock On Steep But Attractive Risk/Reward ↗

January 24, 2023

Needham analyst expects the U.S. ICL market of more than $2.4 billion, despite some investors considering the market to be niche, with STAAR Surgical Company (NASDAQ: STAA) becoming a major player in...

Via Benzinga

Analyst Expectations for Staar Surgical's Future ↗

January 20, 2023

Via Benzinga

Stephens & Co. Maintains Overweight Rating for Staar Surgical: Here's What You Need To Know ↗

December 28, 2022

Via Benzinga

7 Analysts Have This to Say About Staar Surgical ↗

December 28, 2022

Via Benzinga

Neogen Stock Earns Relative Strength Rating Upgrade ↗

January 19, 2023

Neogen stock got a positive adjustment to its Relative Strength (RS) Rating, rising to 79 on Thursday from 66 a day earlier.

Via Investor's Business Daily

Actress and Beauty Entrepreneur Peyton List Sets Her Sights on 2023 with Upgraded Vision from Life-Changing EVO ICL Lenses

January 11, 2023

From STAAR Surgical Company

Via Business Wire

STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022

January 09, 2023

From STAAR Surgical Company

Via Business Wire

Why Shares of STAAR Surgical Jumped 23.7% This Week ↗

January 06, 2023

The new CEO made a major purchase of the company's stock on Monday.

Via The Motley Fool

What 6 Analyst Ratings Have To Say About Staar Surgical ↗

December 08, 2022

Via Benzinga

Expert Ratings for Staar Surgical ↗

October 13, 2022

Analysts have provided the following ratings for Staar Surgical (NASDAQ:STAA) within the last quarter:

Via Benzinga

Goldman Sachs To $492? Here Are 10 Other Price Target Changes For Wednesday ↗

December 28, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

December 20, 2022

On Tuesday, 298 companies achieved new lows for the year.

Via Benzinga

STAAR Surgical CEO Caren Mason to Retire; Tom Frinzi Appointed New CEO

December 19, 2022

From STAAR Surgical Company

Via Business Wire

STAAR Surgical Opens EVO Experience Center in United States

November 17, 2022

From STAAR Surgical Company

Via Business Wire

Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday ↗

November 04, 2022

U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday ↗

November 04, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.

Via Benzinga

What 8 Analyst Ratings Have To Say About Staar Surgical ↗

November 03, 2022

Over the past 3 months, 8 analysts have published their opinion on Staar Surgical (NASDAQ:STAA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Humana To Rally Over 14%? Here Are 5 Other Price Target Changes For Thursday ↗

November 03, 2022

SVB Leerink raised Humana Inc. (NYSE: HUM) price target from $540 to $640. SVB Leerink analyst Whit Mayo maintained the stock with an Outperform rating. Humana shares rose 0.9% to close at $559.58 on...

Via Benzinga

STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y

November 02, 2022

From STAAR Surgical Company

Via Business Wire

STAAR Surgical to Report Third Quarter Results on November 2, 2022

October 19, 2022

From STAAR Surgical Company

Via Business Wire

Earnings Scheduled For November 2, 2022 ↗

November 02, 2022

Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter.

Via Benzinga

Tesla To $230? Plus Canaccord Genuity Cuts PT On T2 Biosystems By 80% ↗

October 14, 2022

Wells Fargo cut the price target on Tesla, Inc. (NASDAQ: TSLA) from $280 to $230. Wells Fargo analyst Colin Langan maintained an Equal-Weight rating on the stock. Tesla shares fell 0.4% to $220.85 in...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 ↗

October 13, 2022

Upgrades

Via Benzinga

Professional Basketball Player Max Strus Kicks Off New Season With Upgraded Vision From Life-Changing EVO ICL Lenses

October 12, 2022

From STAAR Surgical Company

Via Business Wire

How to Find Stocks That Rise 10x ↗

October 10, 2022

Investors looking for 10X stocks should prioritize companies in high-growth areas that demonstrate high earnings quality.

Via InvestorPlace

S&P 500 Dividend Standout Leads 5 Resilient Stocks Near Buy Points As Fed Looms ↗

September 17, 2022

Devon Energy leads this weekend's watch list of stocks in a tough market.

Via Investor's Business Daily

STAAR Surgical Patient Awareness Campaign Launched In New York

September 14, 2022

From STAAR Surgical Company

Via Business Wire

Top-Rated Stocks: Lantheus Stock Sees Composite Rating Climb To 96 ↗

September 01, 2022

Top-rated Lantheus stock saw an improvement in its IBD SmartSelect Composite Rating Thursday, from 94 to 96.

Via Investor's Business Daily

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.